Left Menu
Development News Edition

Shanghai stocks rebound as Beijing talks up policy boost

Reuters | Beijing | Updated: 13-06-2019 13:41 IST | Created: 13-06-2019 13:08 IST
Shanghai stocks rebound as Beijing talks up policy boost
The blue-chip CSI300 index ended a tick down at 3,685.39, while the Shanghai Composite Index closed flat at 2,910.74 points. Image Credit: Pixabay

Shanghai stocks recovered from early losses to end steady on Thursday on hopes Beijing will roll out further measures to bolster the economy amid a bruising trade war with Washington.

The blue-chip CSI300 index ended a tick down at 3,685.39, while the Shanghai Composite Index closed flat at 2,910.74 points. ** Chinese regulators should step up support for the economy and keep ample liquidity in the financial system, Vice Premier Liu He said on Thursday, suggesting Beijing would soon unveil more policies to bolster growth amid rising U.S. trade pressure.

Beijing has plenty of policy tools and is capable of dealing with various challenges, Liu said at a financial forum in Shanghai. ** Liu's comments came amid lingering worries over the Sino-U.S. trade tensions, which put China's economy under pressure.

U.S. President Donald Trump declined to set a deadline on Wednesday for levying tariffs on another $325 billion of Chinese goods and called the relationship with Beijing good but "testy" after China walked back commitments for a trade deal. ** Chinese banks doled out more loans in May to support the slowing economy hurt by a trade war with the United States, with further policy easing likely even amid accelerating consumer inflation.

In an effort to bolster the country's tech strength amid trade war, China on Thursday officially launched Shanghai's Nasdaq-style tech board. ** The picture is mixed for now, as Beijing stepped up support for the economy via financial and monetary policies, though the murky outlook for the Sino-U.S. trade dispute weighed on the market, Donghai Securities noted in the report.

Overall, the A-share market could turn relatively strong, the brokerage added. ** Around the region, MSCI's Asia ex-Japan stock index was weaker by 0.58%, while Japan's Nikkei index closed down 0.46%.

At 0716 GMT, the yuan was quoted at 6.9196 per U.S. dollar, 0.01% weaker than the previous close of 6.9188. ** So far this year, the Shanghai stock index is up 16.7% and the CSI300 rose 22.4%, while China's H-share index listed in Hong Kong is up 2.9%. Shanghai stocks climbed 0.42% so far this month. As of 0717 GMT, China's A-shares were trading at a premium of 27.16% over the Hong Kong-listed H-shares.



5G will be the key driving force for COVID-19 recovery: Here's how?

... ...

Canada’s COVID-19 pitfalls highlight need for integrated health information system

In the globalized world of today where outbreaks can spread far and wide within a matter of days, a global-level integrated health information system is ideal but Canadas provincial barriers show that the country lags much behind in deployi...

Pandemic must be impetus, not obstacle, for clean water access

To make matters worse, there are suspicions that the inadequacy of wastewater treatment methods in California, the rest of the USA, and indeed around the world may help to propagate the disease even more widely. ...

3D printing and the future of manufacturing post COVID-19

The on-demand, customizable, and localized manufacturing of product components facilitated by 3D printing has the potential to redefine manufacturing but there are certain technical, mechanical, and legal limitations that, unless ...


Latest News

Turkey says operations against Kurdish militants in Iraq to continue, urges Baghdad to cooperate

Turkey will continue its cross-border operations against Kurdish militants in northern Iraq if Baghdad continues to overlook the militants presence in the region, the foreign ministry said on Thursday, urging Iraqi authorities to cooperate ...

Zydus Cadila launches COVID-19 drug Remdesivir in India

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most ...

Reuters People News Summary

Following is a summary of current people news briefs. Dwayne Johnson hangs on to top spot on Forbes highest-paid male actors listWrestler-turned-movie star Dwayne Johnson clung to the top slot on the list of the worlds highest-paid male act...

Reuters Sports News Summary

Following is a summary of current sports news briefs. NCAA college football cancellations could send networks, advertisers scrambling into 2021The cancellation of the fall college football season due to the coronavirus pandemic could send n...

Give Feedback